Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Records Second Quarter Income of $291,000 HACKENSACK, NJ / ACCESSWIRE / December 16, 2019 / Champions Oncology, Inc. (NASDAQ:CSBR), engaged in an end-to-end range of research and development technology ...
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
The big shareholder groups in Champions Oncology, Inc. (NASDAQ:CSBR) have power over the company. Institutions will...
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
If you own shares in Champions Oncology, Inc. (NASDAQ:CSBR) then it's worth thinking about how it contributes to the...
In the long-run, does consistent market timing really matter to be a successful investor?
In the long-run, does consistent market timing really matter to be a successful investor?
HACKENSACK, NJ / ACCESSWIRE / November 13, 2019 / Champions Oncology (NASDAQ:CSBR), an end-to-end R&D Oncology solutions company announced today that they have entered into a strategic partnership with ...
Does the January share price for Champions Oncology, Inc. (NASDAQ:CSBR) reflect what it's really worth? Today, we will...
HACKENSACK, NJ / ACCESSWIRE / March 10, 2020 / Champions Oncology, Inc. (CSBR), engaged in an end-to-end range of research and development technology solutions and services to improve the development and use of oncology drugs, today announced it will report its financial and operational results for the third quarter ended January 31, 2020, on Thursday, March 12, 2019, after market close. The company will host a conference call to discuss the results that day at 4:30 p.m. EDT (1:30 p.m. PDT). A replay of the call will be available by dialing 877-481-4010 (Domestic) or 919-882-2331 (International) and entering Passcode: 33556, or by accessing the Investor tab of the company's website within 72 hours.
In 2017 Ronnie Morris was appointed CEO of Champions Oncology, Inc. (NASDAQ:CSBR). This analysis aims first to...
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
HACKENSACK, NJ / ACCESSWIRE / December 9, 2019 / Champions Oncology, Inc. (CSBR), engaged in an end-to-end range of research and development technology solutions and services to improve the development and use of oncology drugs, today announced it will report its financial and operational results for the second quarter ended October 31, 2019, on Monday, December 16, 2019, after market close. The company will host a conference call to discuss the results that day at 4:30 p.m. EST (1:30 p.m. PST). A replay of the call will be available by dialing 877-481-4010 and entering Passcode:56884, or by accessing the Investor tab of the company's website within 72 hours.
HACKENSACK, NJ / ACCESSWIRE / March 12, 2020 / Champions Oncology, Inc. (NASDAQ:CSBR), engaged in an end-to-end range of research and development technology solutions and services to improve the development ...
The Children's Cancer Therapy Development Institute (cc-TDI), Champions Oncology, and The Jackson Laboratory offer rapid, cost-effective services to the pharma, biopharma and biotech industry - speeding ...
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
In the long-run, does consistent market timing really matter to be a successful investor?